ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib Combined With PD-1 & CTLA-4 Inhibition vs. Cabozantinib in Metastatic Soft Tissue Sarcoma"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib Combined With PD-1 & CTLA-4 Inhibition vs. Cabozantinib in Metastatic Soft Tissue Sarcoma"

By ecancer FEATURING Brian Van Tine

81 views

June 15, 2023

Comments 0

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Feat. K. Polson

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Feat. M. Agulnik

2024 Update in Sarcomas

Total Health

D. Portnoy

545 views

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

535 views

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

2024 ESMO Annual Meeting Insights Hub

R. Jones

193 views

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Total Health

B. Wilky

227 views

ASCO® 2024 Highlights in Sarcomas

2024 ASCO® Annual Meeting Insights Hub

R. Jones

224 views

NCCN Clinical Practice Guidelines for Treating GIST

Andrea Napolitano

404 views

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

Warren Chow

352 views

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

2024 ASCO® Annual Meeting Insights Hub

A. Hussein

165 views

Systemic Therapies for Uterine Leiomyosarcoma

OncoAlert

I. Ray-Coquard

335 views

What Is New in Treatment of Soft Tissue and Bone Sarcoma

ISCO - International School of Clinical Oncology

S. Stacchiotti

221 views

Divide and Conquer Sarcomas Through Precision Oncology

Miami Cancer Institute Precision Oncology Symposium

N. Somaiah

107 views

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

i3 Health

S. Patel, B. Ruben, K. Polson

250 views

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Insights from 2023 ESMO Annual Meeting

R. Jones

246 views

Precision Oncology in the Diagnosis and Management of Sarcoma

University of Miami Sylvester Comprehensive Cancer Center

S. Bialick

76 views

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

186 views

Sarcoma Panel Discussion: Molecular Tumor Board - Multidisciplinary …

University of Miami Sylvester Comprehensive Cancer Center

P. Seo, A. Rosenberg, P. Castillo, M. De La Fuente, S. Gultekin, E. Krill-Jackson, C. Gomez

83 views

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

J. Blay

193 views

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

2023 West Oncology Conference

B. Van Tine

514 views

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

178 views

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Du…

2024 ASCO® Annual Meeting Insights Hub

V. Grünwald

73 views

AUTOPLAY

Login

Login

Join VuMedi

ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib Combined With PD-1 & CTLA-4 Inhibition vs. Cabozantinib in Metastatic Soft Tissue Sarcoma"

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Related Videos

2024 Update in Sarcomas

Developmental Therapeutics Highlights From ASCO® 2024

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

ASCO® 2024 Highlights in Sarcomas

NCCN Clinical Practice Guidelines for Treating GIST

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

Systemic Therapies for Uterine Leiomyosarcoma

What Is New in Treatment of Soft Tissue and Bone Sarcoma

Divide and Conquer Sarcomas Through Precision Oncology

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Precision Oncology in the Diagnosis and Management of Sarcoma

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Sarcoma Panel Discussion: Molecular Tumor Board - Multidisciplinary …

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Du…